About
Technology
Issues
FAQ
Links
Official Page
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.